This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Amicogen, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovations of Su Jin Lim
Introduction
Su Jin Lim is a notable inventor based in Jinju, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of enzymes with enhanced properties. His work has implications for the pharmaceutical industry, especially in antibiotic production.
Latest Patents
Su Jin Lim holds a patent for a polypeptide having cephalosporin C acylase activity. This invention is particularly important as it involves a mutant CPC acylase that exhibits improved enzymatic activity and stability. The patent also details the use of this mutant CPC acylase for producing 7-aminocephalosporanic acid (7-ACA), a crucial intermediate in the synthesis of various antibiotics.
Career Highlights
Su Jin Lim is associated with Amicogen, Inc., a company known for its innovative approaches in biotechnology. His work at Amicogen has allowed him to focus on enzyme engineering and its applications in drug development. His contributions have been instrumental in advancing the company's research initiatives.
Collaborations
Su Jin Lim has collaborated with several talented individuals in his field, including Hong Xian Li and Eun Seon Wang. These collaborations have fostered a productive research environment, leading to advancements in their shared projects.
Conclusion
Su Jin Lim's innovative work in enzyme development and his patent for a mutant CPC acylase highlight his significant contributions to biotechnology. His efforts continue to impact the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile